Crossmark

Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-023-02012-5

Published Online: 2023-05-30

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Swoboda, Ryszard https://orcid.org/0000-0002-5897-3919
Kulagin, Alexander https://orcid.org/0000-0002-9589-4136
Velardi, Andrea

Sanz, Jaime https://orcid.org/0000-0001-6934-4619
Labussière-Wallet, Hélène

Potter, Victoria

Kuball, Jürgen https://orcid.org/0000-0002-3914-7806
Sica, Simona

Parovichnikova, Elena

Bethge, Wolfgang https://orcid.org/0000-0001-6052-2618
Maillard, Natacha

Platzbecker, Uwe

Stölzel, Friedrich

Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
License Information

Text and Data Mining valid from 2023-05-30

Version of Record valid from 2023-05-30
More Information

Article History

Received: 13 March 2023

Revised: 7 May 2023

Accepted: 15 May 2023

First Online: 30 May 2023

Competing interests

: The authors declare no competing interests.

: The scientific boards of the ALWP of the EBMT approved this study.

Document is current

Any future updates will be listed below